Skip to main content
OpenTrials

Clinical trial condition

Colonic Diseases

Explore clinical trials studying Colonic Diseases. Study availability and eligibility vary by location and protocol.

7,489 public trials 1,474 recruiting studies
Refine in advanced search Browse all conditions

Colonic Diseases trial results

Active, Not Recruiting

Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Adizutecan (ABBV-400) Moves Through the Body of Adult Participants With Unresectable Locally Advanced/Metastatic Colorectal Cancer

NCT06464692

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • Beijing Cancer Hospital /ID# 263297 Beijing, Beijing Municipality, China
  • The Sixth Affiliated Hospital of Sun Yat-sen University /ID# 263309 Guangzhou, Guangdong, China
  • Harbin Medical University Cancer Hospital /ID# 263049 Harbin, Heilongjiang, China
  • Henan Cancer Hospital /ID# 263172 Zhengzhou, Henan, China
View Trial Details
Active, Not Recruiting

RESOLUTE Trial Aims to Investigate the Value of Adding Local Ablative Treatment to Standard Systemic Treatment for Unresectable Oligometastatic Colorectal Cancer

NCT05862051

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +10 more
Locations
  • Border Medical Oncology Albury, New South Wales, Australia
  • Bendigo Hospital Bendigo, Victoria, Australia
  • Eastern Health Box Hill, Victoria, Australia
  • The Northern Hospital Epping, Victoria, Australia
View Trial Details
Active, Not Recruiting

Combining Sodium Valproate With Standard-of-care EGFR (Epidermal Growth Factor Receptor) Monoclonal Antibody Treatment in Patients With Metastatic Colorectal Cancer

NCT05694936

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • Royal North Shore Hospital Saint Leonards, New South Wales, Australia
  • St Vincent's Hospital Sydney Sydney, New South Wales, Australia
  • Western Sydney Local Health District Westmead, New South Wales, Australia
  • Royal Brisbane and Women's Hospital Herston, Queensland, Australia
View Trial Details
Active, Not Recruiting

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis

NCT06254950

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • GastroIntestinal BioSciences Los Angeles, California, United States
  • United Medical Doctors Murrieta, California, United States
  • West Central Gastroenterology, LLP, d/b/a/ Gastro Florida Clearwater, Florida, United States
  • Auzmer Research Lakeland, Florida, United States
View all 141 locations
View Trial Details
Active, Not Recruiting

Efficacy/Safety of ALTB-268 in Subjects w/Moderately to Severely Active UC Refractory to Biologics

NCT06109441

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • San Diego Gastroenterology San Diego, California, United States
  • Rocky Mountain Gastroenterology Littleton, Colorado, United States
  • Gastro Health Research Miami, Florida, United States
  • Digestive and Liver Center of Florida, LLC Orlando, Florida, United States
View all 24 locations
View Trial Details
Active, Not Recruiting

The Phoenix Trial: Phase II Trial of Cemiplimab for the Non-operative Management of Localized dMMR Colon Cancer

NCT05961709

Conditions
Colon Cancer, Colonic Diseases, Colonic Neoplasms, +9 more
Locations
  • Banner - MD Anderson Cancer Gilbert, Arizona, United States
  • Baptist - MD Anderson Cancer Center Jacksonville, Florida, United States
  • Ochsner New Orleans, Louisiana, United States
  • Cooper University Medical Center Camden, New Jersey, United States
View Trial Details

Related conditions